Acute axonal injury in multiple sclerosis. Correlation with demyelination and inflammation - PubMed (original) (raw)
. 2000 Jun:123 ( Pt 6):1174-83.
doi: 10.1093/brain/123.6.1174.
Affiliations
- PMID: 10825356
- DOI: 10.1093/brain/123.6.1174
Acute axonal injury in multiple sclerosis. Correlation with demyelination and inflammation
A Bitsch et al. Brain. 2000 Jun.
Abstract
Damage to axons is taken as a key factor of disability in multiple sclerosis, but its pathogenesis is largely unknown. Axonal injury is believed to occur as a consequence of demyelination and was recently shown to be a feature even of the early disease stages. The present study was aimed at characterizing the association of axonal injury and histopathological hallmarks of multiple sclerosis such as demyelination, cellular infiltration and expression of inflammatory mediators. Therefore, axon reduction and signs of acute axonal damage were quantified in early lesion development of chronic multiple sclerosis and correlated with demyelinating activity and inflammation. Patients with secondary progressive multiple sclerosis revealed the most pronounced axonal injury, whereas primary progressive multiple sclerosis patients surprisingly showed relatively little acute axonal injury. Acute axonal damage, as defined by the accumulation of amyloid precursor protein (APP), was found to occur not only in active demyelinating but also in remyelinating and inactive demyelinated lesions with a large inter-individual variability. Only few remyelinating lesions were adjacent to areas of active demyelination. In this minority of lesions, axonal damage may have originated from the neighbourhood. APP expression in damaged axons correlated with the number of macrophages and CD8-positive T lymphocytes within the lesions, but not with the expression of tumour necrosis factor-alpha (TNF-alpha) or inducible nitric oxide synthase (iNOS). Axonal injury is therefore, at least in part, independent of demyelinating activity, and its pathogenesis may be different from demyelination. This has major implications for therapeutic strategies, which aim at preventing both demyelination and axonal loss.
Similar articles
- Multiple sclerosis and chronic autoimmune encephalomyelitis: a comparative quantitative study of axonal injury in active, inactive, and remyelinated lesions.
Kornek B, Storch MK, Weissert R, Wallstroem E, Stefferl A, Olsson T, Linington C, Schmidbauer M, Lassmann H. Kornek B, et al. Am J Pathol. 2000 Jul;157(1):267-76. doi: 10.1016/S0002-9440(10)64537-3. Am J Pathol. 2000. PMID: 10880396 Free PMC article. - Acutely damaged axons are remyelinated in multiple sclerosis and experimental models of demyelination.
Schultz V, van der Meer F, Wrzos C, Scheidt U, Bahn E, Stadelmann C, Brück W, Junker A. Schultz V, et al. Glia. 2017 Aug;65(8):1350-1360. doi: 10.1002/glia.23167. Epub 2017 May 31. Glia. 2017. PMID: 28560740 Free PMC article. - Oxidative stress and proinflammatory cytokines contribute to demyelination and axonal damage in a cerebellar culture model of neuroinflammation.
di Penta A, Moreno B, Reix S, Fernandez-Diez B, Villanueva M, Errea O, Escala N, Vandenbroeck K, Comella JX, Villoslada P. di Penta A, et al. PLoS One. 2013;8(2):e54722. doi: 10.1371/journal.pone.0054722. Epub 2013 Feb 19. PLoS One. 2013. PMID: 23431360 Free PMC article. - Neuropathology in multiple sclerosis: new concepts.
Lassmann H. Lassmann H. Mult Scler. 1998 Jun;4(3):93-8. doi: 10.1177/135245859800400301. Mult Scler. 1998. PMID: 9762654 Review. - The pathology of multiple sclerosis is the result of focal inflammatory demyelination with axonal damage.
Brück W. Brück W. J Neurol. 2005 Nov;252 Suppl 5:v3-9. doi: 10.1007/s00415-005-5002-7. J Neurol. 2005. PMID: 16254699 Review.
Cited by
- Deferoxamine preconditioning of canine stem cell derived extracellular vesicles alleviates inflammation in an EAE mouse model through STAT3 regulation.
Park SM, Oh YH, Lim GH, Yun GH, Kim KB, An JH, Seo KW, Youn HY. Park SM, et al. Sci Rep. 2024 Aug 20;14(1):19273. doi: 10.1038/s41598-024-68853-2. Sci Rep. 2024. PMID: 39164295 Free PMC article. - Association between peripheral blood immunological status and intrathecal inflammatory markers differentiate multiple sclerosis clinical phenotypes.
Turčić A, Knežević J, Zaninović L, Habek M, Skorić MK, Babić A, Vogrinc Ž. Turčić A, et al. Acta Neurol Belg. 2024 Aug 3. doi: 10.1007/s13760-024-02597-8. Online ahead of print. Acta Neurol Belg. 2024. PMID: 39095573 - Targeting the muscarinic M1 receptor with a selective, brain-penetrant antagonist to promote remyelination in multiple sclerosis.
Poon MM, Lorrain KI, Stebbins KJ, Edu GC, Broadhead AR, Lorenzana AJ, Roppe JR, Baccei JM, Baccei CS, Chen AC, Green AJ, Lorrain DS, Chan JR. Poon MM, et al. Proc Natl Acad Sci U S A. 2024 Aug 6;121(32):e2407974121. doi: 10.1073/pnas.2407974121. Epub 2024 Jul 31. Proc Natl Acad Sci U S A. 2024. PMID: 39083422 Free PMC article. - Combining imaging mass spectrometry and immunohistochemistry to analyse the lipidome of spinal cord inflammation.
Calvo I, Montilla A, Huergo C, Martín-Saiz L, Martín-Allende J, Tepavcevic V, Domercq M, Fernández JA. Calvo I, et al. Anal Bioanal Chem. 2024 Mar;416(8):1923-1933. doi: 10.1007/s00216-024-05190-3. Epub 2024 Feb 7. Anal Bioanal Chem. 2024. PMID: 38326664 Free PMC article. - Association of helicobacter pylori with multiple sclerosis: Protective or risk factor?
Mirmosayyeb O, Barzegar M, Nehzat N, Najdaghi S, Ansari B, Shaygannejad V. Mirmosayyeb O, et al. Curr J Neurol. 2020 Apr 3;19(2):59-66. doi: 10.18502/cjn.v19i2.4942. Curr J Neurol. 2020. PMID: 38011437 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials